Industry News
Print
Kaiser Family Foundation Publishes FAQs on Prescription Drug Importation
On February 24, 2020, the Kaiser Family Foundation (KFF) published its issue brief, 10 FAQs on Prescription Drug Importation. The FAQs provide information related to recent proposals to import prescription drugs from Canada and other countries in an effort to help lower drug prices for Americans. In addition, they provide background information on drug importation in the U.S. and the challenges faced by previous importation proposals.
Some of the FAQs include:
- Why is importation of prescription drugs from Canada being considered as a way to lower drug costs in the U.S.?
- What are the safety concerns related to importation of prescription drugs and why hasn’t it been implemented before?
- What has the Trump Administration proposed regarding importation?
- What is the estimated savings from the Administration’s importation plan?
The FAQs are available here.